Assesses body composition relation to metabolic dysfunction-associated fatty liver disease severity, indicating the role of visceral fat.
Background: Metabolic dysfunction–associated fatty liver disease (MAFLD) is strongly associated with obesity and metabolic dysfunction. Visceral adiposity plays a central role in disease progression from steatosis to fibrosis. Bioimpedance analysis (BIA) offers a simple and non-invasive method for evaluating body composition.
No takes yet. Share an insight, caveat, or question.
Zohidjon Asqarali ugli Umarov (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: